| Product Code: ETC7633696 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Malaria Vaccine Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Malaria Vaccine Market - Industry Life Cycle |
3.4 Ireland Malaria Vaccine Market - Porter's Five Forces |
3.5 Ireland Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Ireland Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about malaria prevention and vaccination in Ireland |
4.2.2 Government initiatives to control and eliminate malaria in the country |
4.2.3 Growing investments in research and development for malaria vaccines |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of malaria vaccines in Ireland |
4.3.2 High cost associated with malaria vaccination |
4.3.3 Lack of proper infrastructure for distribution and administration of malaria vaccines |
5 Ireland Malaria Vaccine Market Trends |
6 Ireland Malaria Vaccine Market, By Types |
6.1 Ireland Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Ireland Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Ireland Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Ireland Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Ireland Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Ireland Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Ireland Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Ireland Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Ireland Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Ireland Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Ireland Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Ireland Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Ireland Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Ireland Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Ireland Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Ireland Malaria Vaccine Market Export to Major Countries |
7.2 Ireland Malaria Vaccine Market Imports from Major Countries |
8 Ireland Malaria Vaccine Market Key Performance Indicators |
8.1 Number of malaria vaccination campaigns conducted in Ireland |
8.2 Percentage increase in government funding towards malaria prevention programs |
8.3 Number of healthcare facilities offering malaria vaccination services |
9 Ireland Malaria Vaccine Market - Opportunity Assessment |
9.1 Ireland Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Ireland Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Malaria Vaccine Market - Competitive Landscape |
10.1 Ireland Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Ireland Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here